AFM
TCON

Anson Funds Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Anson Funds Management’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,251
Closed -$158K – 56
2018
Q4 		$158K Buy
+1,251
New +$340K 0.09% 44

Other funds holding TCON

PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Anson Funds Management's TCON Position: Q1 2019 in Review

Anson Funds Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q1 2019, closing a stake of 1,251 shares — an estimated $158K sold.

Anson Funds Management first reported a position in TCON in Q4 2018 and held it in 1 quarter. The position peaked at $158K in Q4 2018. 24 funds tracked by Wall St. Rank hold TCON as of Q1 2019.

  • Anson Funds Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Anson Funds Management sold 1,251 TRACON Pharmaceuticals, Inc. Common Stock shares in Q1 2019, an estimated $158K.
  • Anson Funds Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Anson Funds Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $158K in Q4 2018.
  • 24 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on Anson Funds Management's 13F filing for Q1 2019, filed 15 May 2019.